Results 91 to 100 of about 7,708 (214)

Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study

open access: yes, 2011
Atherothrombosis is a multifactorial process, governed by an interaction between the vessel wall, hemodynamic factors and systemic atherothrombotic risk factors.
Suzanne Battjes   +22 more
core   +1 more source

Differentiated thyroid cancer in patients with prolactinoma

open access: yes, 2016
© TÜBİTAK.Background/aim: Increasing evidence is available about the role of prolactin in the development of various cancers. The purpose of this study is to evaluate the frequency of thyroid cancer in patients with prolactinoma followed at a single site.
Tam, ABBAS ALİ   +4 more
core   +1 more source

Plasma Leptin Levels Before and After Bromocriptine Treatment in Female Patients with Prolactinoma

open access: yesEndocrinology Research and Practice, 2022
Both It is known that increased body weight is associated with prolactinomas. However, effects of bromocriptine treatment on plasma leptin levels is not clear yet.
Metin Özata   +2 more
doaj  

YouTube and Prolactinoma: Assessing the Impact on Patient Knowledge [PDF]

open access: yes
Purpose With the increasing access to the internet worldwide, In medicine, patients have been using this tool to look for treatment for some medical topics.
Garzón Molina, Claudia Ximena   +5 more
core  

Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients.

open access: yes, 2013
Prolactinoma is the most frequent pituitary tumour among women of child-bearing age. Only a few studies have addressed the outcome of prolactinoma after pregnancy.JOURNAL ARTICLESCOPUS: ar.jFLWINinfo:eu-repo/semantics ...
Devuyst, France   +4 more
core   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Transcriptomic analysis of the anti-tumor effects of leflunomide in prolactinoma

open access: yesScientific Reports
Leflunomide’s anti-tumor effects have been investigated in various types of tumors; however, its impact on pituitary adenoma, particularly prolactinoma, is unclear.
Xiangdong Pei   +6 more
doaj   +1 more source

Modern approach to bone comorbidity in prolactinoma

open access: yes
Prolactinomas account for more than half of pituitary adenomas, and besides their clinical impact on fertility and gonadal function, they lead to detrimental effects on bone.
Menotti, Sara   +3 more
core   +1 more source

A case of rapidly increasing cabergoline-resistant male prolactinoma

open access: yesInterdisciplinary Neurosurgery
Cabergoline, a dopamine agonist, is the first-line drug for treating prolactinoma. However, some rare cases exhibit resistance to cabergoline. Here, we report a rare case of prolactinoma in a male patient that recurred in a short period while the patient
Toshiya Ichinose   +2 more
doaj   +1 more source

High-Risk Prostate Cancer in a Patient with Untreated Prolactinoma and Castrate-Level Testosterone Suppression: A Case Report

open access: yesCase Reports in Oncology
Introduction: Prolactinomas can induce castrate-level testosterone suppression by dysregulating the hypothalamic-pituitary-gonadal axis. While hypogonadism typically confers a reduced risk for prostate cancer (PCa), malignancy can still occur ...
Tara A. Seibert   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy